Search by Drug Name or NDC
NDC 60505-6243-04 Cefazolin 1 g/1 Details
Cefazolin 1 g/1
Cefazolin is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is CEFAZOLIN SODIUM.
MedlinePlus Drug Summary
Cefazolin injection is used to treat certain infections caused by bacteria including skin, bone, joint, genital, blood, heart valve, respiratory tract (including pneumonia), biliary tract, and urinary tract infections. Cefazolin injection also may be used before, during, and sometimes for a brief period after surgery in order to prevent the patient from getting an infection. Cefazolin injection is in a class of medications called cephalosporin antibiotics. It works by killing bacteria. Antibiotics such as cefazolin injection will not work for colds, flu, or other viral infections. Taking antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 60505-6243-04Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cefazolin Injection
Product Information
| NDC | 60505-6243 |
|---|---|
| Product ID | 60505-6243_90d68812-6ff8-4372-a838-b415162dd40e |
| Associated GPIs | |
| GCN Sequence Number | 009065 |
| GCN Sequence Number Description | cefazolin sodium VIAL 1 G INJECTION |
| HIC3 | W1W |
| HIC3 Description | CEPHALOSPORIN ANTIBIOTICS - 1ST GENERATION |
| GCN | 39903 |
| HICL Sequence Number | 003976 |
| HICL Sequence Number Description | CEFAZOLIN SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Cefazolin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cefazolin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 1 |
| Active Ingredient Units | g/1 |
| Substance Name | CEFAZOLIN SODIUM |
| Labeler Name | Apotex Corp. |
| Pharmaceutical Class | Cephalosporin Antibacterial [EPC], Cephalosporins [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203661 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 60505-6243-04 (60505624304)
| NDC Package Code | 60505-6243-4 |
|---|---|
| Billing NDC | 60505624304 |
| Package | 25 VIAL, SINGLE-DOSE in 1 CARTON (60505-6243-4) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (60505-6243-0) |
| Marketing Start Date | 2022-09-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |